LPS converts Gr-1(+)CD115(+) myeloid-derived suppressor cells from M2 to M1 via P38 MAPK. (Q45820540)

16 December 2017

title

LPS converts Gr-1(+)CD115(+) myeloid-derived suppressor cells from M2 to M1 via P38 MAPK. (English)

1 reference

16 December 2017

author name string

Yi Yang

1

1 reference

16 December 2017

Ruihua Zhang

2

1 reference

16 December 2017

Fei Xia

3

1 reference

16 December 2017

Ting Zou

4

1 reference

16 December 2017

Anfei Huang

5

1 reference

16 December 2017

Sidong Xiong

6

1 reference

16 December 2017

Jinping Zhang

7

1 reference

16 December 2017

language of work or name

English

0 references

publication date

20 May 2013

1 reference

16 December 2017

Experimental Cell Research

published in

1 reference

16 December 2017

volume

319

1 reference

16 December 2017

issue

12

1 reference

16 December 2017

page(s)

1774-1783

1 reference

16 December 2017

The terminology issue for myeloid-derived suppressor cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Altered macrophage differentiation and immune dysfunction in tumor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Role of immature myeloid cells in mechanisms of immune evasion in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Immunosuppressive strategies that are mediated by tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Intact glycans from cestode antigens are involved in innate activation of myeloid suppressor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Induced SHIP deficiency expands myeloid regulatory cells and abrogates graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Antigen specificity of immune suppression by myeloid-derived suppressor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(+) macrophages that suppress naive CD4(+) T cell proliferation via an IFN-gamma and nitric oxide-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

7 January 2021

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

The new B7s: playing a pivotal role in tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Tumor versus tumor-associated macrophages: how hot is the link?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Macrophage polarization in tumour progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Modulation of regulatory T cells in health and disease: role of toll-like receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Stat proteins and oncogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Myeloid-derived suppressor cells as regulators of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Infection and cancer: revaluation of the hygiene hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.05.007

10.1016/J.YEXCR.2013.05.007

7 January 2021

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017